Unknown

Dataset Information

0

Enhanced bypass of PD-L1 translation reduces the therapeutic response to mTOR kinase inhibitors.


ABSTRACT: Increased PD-L1 expression in cancer cells is known to enhance immunosuppression, but the mechanism underlying PD-L1 upregulation is incompletely characterized. We show that PD-L1 expression is upregulated through internal ribosomal entry site (IRES)-mediated translation upon mTORC1 inhibition. We identify an IRES element in the PD-L1 5'-UTR that permits cap-independent translation and promotes continuous production of PD-L1 protein despite effective inhibition of mTORC1. eIF4A is found to be a key PD-L1 IRES-binding protein that enhances PD-L1 IRES activity and protein production in tumor cells treated with mTOR kinase inhibitors (mTORkis). Notably, treatment with mTORkis in vivo elevates PD-L1 levels and reduces the number of tumor-infiltrating lymphocytes in immunogenic tumors, but anti-PD-L1 immunotherapy restores antitumor immunity and enhances the therapeutic efficacy of mTORkis. These findings report a molecular mechanism for regulating PD-L1 expression through bypassing mTORC1-mediated cap-dependent translation and provide a rationale for targeting PD-L1 immune checkpoint to improve mTOR-targeted therapy.

SUBMITTER: Cao Y 

PROVIDER: S-EPMC10491412 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Enhanced bypass of PD-L1 translation reduces the therapeutic response to mTOR kinase inhibitors.

Cao Yanan Y   Ye Qing Q   Ma Murong M   She Qing-Bai QB  

Cell reports 20230704 7


Increased PD-L1 expression in cancer cells is known to enhance immunosuppression, but the mechanism underlying PD-L1 upregulation is incompletely characterized. We show that PD-L1 expression is upregulated through internal ribosomal entry site (IRES)-mediated translation upon mTORC1 inhibition. We identify an IRES element in the PD-L1 5'-UTR that permits cap-independent translation and promotes continuous production of PD-L1 protein despite effective inhibition of mTORC1. eIF4A is found to be a  ...[more]

Similar Datasets

| S-EPMC11705730 | biostudies-literature
| S-EPMC4496233 | biostudies-literature
| S-EPMC8120466 | biostudies-literature
| S-EPMC4516625 | biostudies-literature
| S-EPMC4930724 | biostudies-literature
| S-EPMC6403384 | biostudies-literature
| S-EPMC6367228 | biostudies-literature
| S-EPMC9995465 | biostudies-literature
| S-EPMC6685986 | biostudies-literature
| S-EPMC7987916 | biostudies-literature